104 related articles for article (PubMed ID: 21115941)
21. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
22. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
[TBL] [Abstract][Full Text] [Related]
24. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
[TBL] [Abstract][Full Text] [Related]
25. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
[TBL] [Abstract][Full Text] [Related]
26. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M
Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295
[TBL] [Abstract][Full Text] [Related]
27. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
28. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Millis RR; Springall RJ; Hanby AM; Ryder K; Fentiman IS
Cancer; 2002 Apr; 94(8):2307-9. PubMed ID: 12001132
[No Abstract] [Full Text] [Related]
29. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
31. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
33. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
[TBL] [Abstract][Full Text] [Related]
34. Expression of aquaporin1, a water channel protein, in cytoplasm is negatively correlated with prognosis of breast cancer patients.
Qin F; Zhang H; Shao Y; Liu X; Yang L; Huang Y; Fu L; Gu F; Ma Y
Oncotarget; 2016 Feb; 7(7):8143-54. PubMed ID: 26812884
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of patients with locally recurrent breast cancer.
Voogd AC; van Tienhoven G
Am J Surg; 2007 Jan; 193(1):138. PubMed ID: 17188110
[No Abstract] [Full Text] [Related]
36. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors in lymph node negative breast cancer patients].
Brockmann B; Wildner GP
Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):413-8. PubMed ID: 1615724
[No Abstract] [Full Text] [Related]
38. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
39. Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer.
Mariani A; Webb MJ; Rao SK; Lesnick TG; Podratz KC
Gynecol Oncol; 2001 Feb; 80(2):113-20. PubMed ID: 11161847
[TBL] [Abstract][Full Text] [Related]
40. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
